Erech Finance Cahalacha Ltd (TLV:EFNC.M)
Israel · Delayed Price · Currency is ILS · Price in ILA 145.80
-8.20 (-5.32%)
At close: Oct 15, 2026
Erech Finance Cahalacha Market Cap
Erech Finance Cahalacha has a market cap or net worth of 3.79 million as of October 23, 2026. Its market cap has decreased by 51.48% in one year.
Market Cap
3.79M
Enterprise Value
n/a
Revenue
-2.93M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since May 1, 2018, Erech Finance Cahalacha's market cap has decreased from 49.94M to 3.79M, a decrease of -92.41%. That is a compound annual growth rate of -26.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 3.79M | 11.82% |
| Dec 31, 2025 | 3.39M | -33.13% |
| Dec 31, 2024 | 5.07M | -56.90% |
| Dec 31, 2023 | 11.77M | -24.56% |
| Dec 29, 2022 | 15.60M | -81.97% |
| Dec 30, 2021 | 86.49M | -32.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.75B |
| Amal Holdings A.D. | 2.16B |
| Rafa Laboratories | 1.82B |
| BrainsWay | 1.39B |
| Can-Fite BioPharma | 18.04M |
| Evogene | 17.89M |
| PsyRX CNS Bio-Tech | 8.19M |
| MediPress Health-Limited Partnership | 7.81M |